Trial NCT01433991

View at ClinicalTrials.gov 
Org. Study IDs: E7050-G000-901

Last trial update was posted on 2021-06-08

MeSH Interventions

Lenvatinib

MeSH Conditions

Glioblastoma

Other Conditions

Advanced Solid Tumors

Stopping Reasons

Study was terminated by the sponsor early at the end of Phase 1b due to a change in corporate strategy.

Limitations And Caveats

The study was terminated by the sponsor at the end of Phase 1b due to a change in corporate strategy, hence Phase 2 was not carried out.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID